How to Buy Akero Therapeutics Stock

Akero Therapeutics Inc

Akero Therapeutics, Inc. , a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health.

Akero Therapeutics stock last closed at $47.72, up 0.48% from the previous day, and has increased 79.33% in one year. It has overperformed other stocks in the Biotechnology industry by 1.47 percentage points. Akero Therapeutics stock is currently +123.62% from its 52-week low of $21.34, and -18.29% from its 52-week high of $58.40.

There are currently 79.72M AKRO shares outstanding. The market value of AKRO is $3.80B. In the last 24 hours, 1.16M AKRO shares were traded.

How to Buy Akero Therapeutics Stock

Wondering how to invest in Akero Therapeutics stock? Here's how.

  1. Choose where to buy Akero Therapeutics stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Akero Therapeutics stock.
  2. Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Deposit money your brokerage account: Pick your payment method and add your information.
  4. Analyze Akero Therapeutics stock: The Akero Therapeutics ticker symbol is AKRO. Is Akero Therapeutics stock a good investment? Should you buy shares of AKRO? How do AKRO's underlying business fundamentals look? Do top analysts think Akero Therapeutics is a good buy? Why has AKRO's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if AKRO is a good stock to buy).
  5. Execute your AKRO purchase: Decide if you will purchase AKRO shares at the current market price or use a limit order to buy AKRO shares at a particular price.
  6. Monitor your AKRO investment: Create a watchlist to keep tabs on your investment in Akero Therapeutics shares.

Step 1: Choose where to buy Akero Therapeutics stock

You need an online brokerage account in order to access the NASDAQ market and buy AKRO stock.

A brokerage account enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

We believe that eToro is the best stock brokerage. Here's why:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to global markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've chosen the best brokerage, it's time to fill out some personal information so you can buy AKRO stock today.

How to Create a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal info to create a new brokerage account.
  1. Send your details by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your brokerage account

Now that you have filled out your info on apps for stock market, you need to deposit funds:

Check out the walkthrough below if you need help depositing funds into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Akero Therapeutics stock

Once you have selected the best place to buy Akero Therapeutics stock, it's crucial to analyze their stock before you invest, so you can understand the risk as well as the upside.

Akero Therapeutics shares at a glance

AKRO Price
$47.72
1w %
-7.91%
1y %
79.33%
5y %
32.12%
P/E
-12.73x
P/B
3.51x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$269.44M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$3.80B
Next Earnings
Aug 8, 2025
Next Dividend
N/A

AKRO Due Diligence Checks

WallStreetZen was created to help part-time investors perform more accurate fundamental analysis quickly.

You can see all of the due diligence checks on AKRO's stock page.

Is AKRO stock properly valued?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge AKRO's fair value.

Using relative valuations metrics:

  • AKRO may be undervalued based on its P/B ratio of 3.51x, relative to Biotechnology industry P/B ratio of 4.34x

You can access more valuation research on AKRO's stock here.

AKRO Financial Summary

Positive Health Checks:

  • Total AKRO debt is lower than 5 years ago, relative to shareholder equity.
  • There are more short-term assets than short-term liabilities on the AKRO balance sheet.
  • AKRO has a low debt to equity ratio of 0.07.
  • AKRO has $686.29M in cash and short term investments. This is sufficient to cover its annual cash burn of $262.63M.
  • There are more short-term assets than long-term liabilities on the AKRO balance sheet.
  • AKRO has cash burn of 262631000. It has enough cash and short-term investments to cover this for at least one year.

Is it a good time to buy AKRO stock, according to Wall Street analysts?

Out of 4 sell side analysts who give forecasts on AKRO, the consensus analyst rating on AKRO is a Strong Buy

Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.

You can dig deeper into what analysts are saying on the Akero Therapeutics stock forecast page.

AKRO Momentum

SMA10
50.7
SMA20
51.27
SMA50
51.58
SMA100
46.4
SMA200
40.89
MACD
-0.79
MACD Signal
-0.16
MACD Histogram
-0.63
RSI
36.05
Stochastic %K
5.21
Stochastic %D
7.41
StochRSI %K
1.61
StochRSI %D
1.19

Are AKRO executives and large shareholders buying or selling the stock?

In the last 12 months, insiders at AKRO have bought more shares than they have sold.

Catriona Yale, Chief Development Officer of AKRO, was the latest AKRO insider to buy. They bought $198,700.00 worth of AKRO shares on Jul 16, 2025.

Dig into more about who owns AKRO stock here.

Can I rely on AKRO as an income stream?

No, Akero Therapeutics doesn't provide an income stream by paying out dividends.

What others are saying about AKRO

One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to see what other traders have to say.

Step 5: Execute your AKRO purchase

There are two main order types:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are mostly sufficient.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at a specific dollar amount, use a limit order.

Click the Open Trade button and eToro will execute your order.

If you require additional help buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Monitor your AKRO investment

Now that you own some AKRO stock, you'll want to keep up with your new stock purchase.

Start a watchlist to track the latest developments regarding your AKRO stock.

AKRO Feed

How to Buy Stock in Akero Therapeutics

To summarize, here are the 6 steps you need to take to buy Akero Therapeutics stock right now:

  1. Choose where to buy Akero Therapeutics stock
  2. Sign up for your brokerage account
  3. Deposit money your brokerage account
  4. Analyze Akero Therapeutics stock
  5. Execute your AKRO purchase
  6. Monitor your AKRO investment

If you are looking for a online brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep tabs on your new investment in Akero Therapeutics, hit the button below to create your watchlist.

NASDAQ: AKRO
$47.72+0.23 (+0.48%)
Updated Jul 30, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: AKRO
$47.72+0.23 (+0.48%)
Updated Jul 30, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Akero Therapeutics share?

As of Jul 30, 2025, it costs $47.72 to buy one share of Akero Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.21 shares of AKRO.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Akero Therapeutics stock?

According to 4 Wall Street analysts who monitor Akero Therapeutics, their consensus recommendation is to buy Akero Therapeutics stock.

What is the best way to buy Akero Therapeutics stock?

One way to place an order for Akero Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.